Walleye Capital
RCKT icon

Walleye Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Walleye Capital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+60,411
New +$201K ﹤0.01% 3485
2026
Q1 		– Sell
-499,331
Closed -$1.75M – 4880
2025
Q4 		$1.75M Sell
499,331
-126,202
-20% -$432K 0.01% 1979
2025
Q3 		$2.04M Buy
625,533
+49,482
+9% +$156K 0.01% 1564
2025
Q2 		$1.41M Buy
576,051
+288,963
+101% +$1.46M 0.01% 1778
2025
Q1 		$1.91M Buy
287,088
+66,946
+30% +$661K 0.01% 1452
2024
Q4 		$2.77M Buy
220,142
+81,739
+59% +$1.23M 0.01% 1481
2024
Q3 		$2.56M Buy
+138,403
New +$2.83M 0.01% 1724
2022
Q4 		– Sell
-17,121
Closed -$273K – 3553
2022
Q3 		$273K Buy
+17,121
New +$267K 0.01% 1895

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Walleye Capital's RCKT Position: Q2 2026 in Review

Walleye Capital opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 60,411 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #3485 among its holdings. This is a return to the name: Walleye Capital previously reported a position in RCKT as recently as Q4 2025.

Walleye Capital first reported a position in RCKT in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.77M in Q4 2024. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Walleye Capital held 60,411 shares of Rocket Pharmaceuticals worth $207K as of Q2 2026.
  • Rocket Pharmaceuticals was a new Walleye Capital position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3485 holding.
  • Walleye Capital first reported a position in Rocket Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
  • Walleye Capital's Rocket Pharmaceuticals position peaked at $2.77M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.